Diagnosis and evaluation of patients with osteoporosis : Featured CME Topic: OsteoporosisWATTS, Nelson B.Southern medical journal (Birmingham). 2004, Vol 97, Num 6, pp 540-541, issn 0038-4348, 2 p.Article

OsteoporosisWATTS, Nelson B.Endocrinology and metabolism clinics of North America. 1998, Vol 27, Num 2, issn 0889-8529, 258 p.Serial Issue

The role of fluoride in the prevention of osteoporosisKLEEREKOPER, M.Endocrinology and metabolism clinics of North America. 1998, Vol 27, Num 2, pp viii-ix, issn 0889-8529, 14 p.Article

The role of estrogen in the prevention of osteoporosisLINDSAY, R.Endocrinology and metabolism clinics of North America. 1998, Vol 27, Num 2, issn 0889-8529, viii,399-409 [12 p.]Article

Treatment of osteoporosis with bisphosphonatesWATTS, Nelson B.Rheumatic diseases clinics of North America. 2001, Vol 27, Num 1, pp 197-214, issn 0889-857XArticle

Risk factors for osteoporotic fractureROSS, P. D.Endocrinology and metabolism clinics of North America. 1998, Vol 27, Num 2, issn 0889-8529, vi,289-301 [14 p.]Article

Bisphosphonates in the Treatment of OsteoporosisDIAB, Dima L; WATTS, Nelson B.Endocrinology and metabolism clinics of North America (Print). 2012, Vol 41, Num 3, issn 0889-8529, v, 487-506 [11 p.]Article

The roles of calcium and vitamin D in the prevention of osteoporosisREID, I. R.Endocrinology and metabolism clinics of North America. 1998, Vol 27, Num 2, pp vii-viii, issn 0889-8529, 12 p.Article

Osteoporosis in menORWOLL, E. S.Endocrinology and metabolism clinics of North America. 1998, Vol 27, Num 2, issn 0889-8529, vii,349-367 [20 p.]Article

The science and therapy of glucocorticoid-induced bone lossLANE, N. E; LUKERT, B.Endocrinology and metabolism clinics of North America. 1998, Vol 27, Num 2, issn 0889-8529, ix,465-483 [20 p.]Article

New Guidelines for the Prevention and Treatment of OsteoporosisLEWIECKI, E. Michael; WATTS, Nelson B.Southern medical journal (Birmingham, Ala. Print). 2009, Vol 102, Num 2, pp 175-179, issn 0038-4348, 5 p.Article

Osteonecrosis of the JawWATTS, Nelson B; MARCIANI, Robert D.Southern medical journal (Birmingham). 2008, Vol 101, Num 2, pp 160-165, issn 0038-4348, 6 p.Article

Combination therapy for postmenopausal osteoporosisCOMPSTON, Juliet E; WATTS, Nelson B.Clinical endocrinology (Oxford. Print). 2002, Vol 56, Num 5, pp 565-569, issn 0300-0664Article

Biochemical markers of bone turnover: Applications for osteoporosisGARNERO, P; DELMAS, P. D.Endocrinology and metabolism clinics of North America. 1998, Vol 27, Num 2, pp vi-vii, issn 0889-8529, 23 p.Article

The role of calcitonin in the prevention of osteoporosisAVIOLI, L. V.Endocrinology and metabolism clinics of North America. 1998, Vol 27, Num 2, issn 0889-8529, viii,411-418 [9 p.]Article

Treatment of osteoporosis with bisphosphonatesWATTS, N. B.Endocrinology and metabolism clinics of North America. 1998, Vol 27, Num 2, issn 0889-8529, viii,419-439 [22 p.]Article

Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate : Reduction in risk of nonvertebral fracture is not related to change in BMDWATTS, Nelson B; GEUSENS, Piet; BARTON, Ian P et al.Journal of bone and mineral research (Print). 2005, Vol 20, Num 12, pp 2097-2104, issn 0884-0431, 8 p.Article

Secondary osteoporosis: Diagnostic considerationsHARPER, K. D; WEBER, T. J.Endocrinology and metabolism clinics of North America. 1998, Vol 27, Num 2, issn 0889-8529, vii,325-348 [25 p.]Article

Recommendations for the Clinical Evaluation of Agents for Treatment of Osteoporosis : Consensus of an Expert Panel Representing the American Society for Bone and Mineral Research (ASBMR), the International Society for Clinical Densitometry (ISCD), and the National Osteoporosis Foundation (NOF)SILVERMAN, Stuart L; CUMMINGS, Steven R; WATTS, Nelson B et al.Journal of bone and mineral research (Print). 2008, Vol 23, Num 1, pp 159-165, issn 0884-0431, 7 p.Article

Assessment of non-vertebral fracture risk in postmenopausal womenROUX, Christian; BRIOT, Karine; HORLAIT, Stéphane et al.Annals of the rheumatic diseases. 2007, Vol 66, Num 7, pp 931-935, issn 0003-4967, 5 p.Article

Therapy for osteoporosis: Miscellaneous and experimental agentsREGINSTER, J.-Y; TAQUET, A. N; GOSSET, C et al.Endocrinology and metabolism clinics of North America. 1998, Vol 27, Num 2, issn 0889-8529, ix,453-463 [12 p.]Article

The roles of exercise and fall risk reduction in the prevention of osteoporosisHENDERSON, N. K; WHITE, C. P; EISMAN, J. A et al.Endocrinology and metabolism clinics of North America. 1998, Vol 27, Num 2, issn 0889-8529, vii,369-387 [20 p.]Article

Managing patients with complications of osteoporosisGOLD, D. T; SHIPP, K. M; LYLES, K. W et al.Endocrinology and metabolism clinics of North America. 1998, Vol 27, Num 2, issn 0889-8529, ix,485-496 [13 p.]Article

Effect of osteoporosis treatments on risk of non-vertebral fractures : review and meta-analysis of intention-to-treat studiesBOONEN, Steven; LAAN, Roland F; BARTON, Ian P et al.Osteoporosis international. 2005, Vol 16, Num 10, pp 1291-1298, issn 0937-941X, 8 p.Article

Risk Factors for the Development of Osteoporosis and Osteoporotic Fractures Among Older MenTHOMAS-JOHN, Maria; CODD, Mary B; MANNE, Sialaja et al.Journal of rheumatology. 2009, Vol 36, Num 9, pp 1947-1952, issn 0315-162X, 6 p.Article